Entry |
|
Name |
Survodutide (USAN/INN) |
Formula |
C192H289N47O61
|
Exact mass |
4229.0957
|
Mol weight |
4231.6274
|
Sequence |
(A chain) HXQGTFTSDY SKYLDERAAK DFIKWLESA (B chain) EGSGSGG (Amide bridge: A24-B7) |
Type |
Peptide |
Class |
Antidiabetic agent
DG02044 Hypoglycemic agent
DG01493 GLP-1 receptor agonist
|
Efficacy |
Glucagon-like peptide 1 (GLP-1) receptor agonist, Glucagon receptor agonist |
Comment |
Treatment of obesity and non-alcoholic steatohepatitis (NASH)
|
Target |
|
Pathway |
hsa04080 | Neuroactive ligand-receptor interaction |
|
Interaction |
|
Brite |
Drug groups [BR:br08330]
Antidiabetic agent
DG02044 Hypoglycemic agent
DG01493 GLP-1 receptor agonist
D12898 Survodutide
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Secretin receptor family
Glucagon
GLP1R
D12898 Survodutide (USAN/INN)
GCGR
D12898 Survodutide (USAN/INN)
|
Other DBs |
|
LinkDB |
|